Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Settings
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E78.81 EPS (ttm)2.67 Insider Own2.30% Shs Outstand342.18M Perf Week2.48%
Market Cap72.00B Forward P/E14.53 EPS next Y14.48 Insider Trans4.96% Shs Float333.04M Perf Month6.81%
Income913.50M PEG3.46 EPS next Q2.34 Inst Own66.80% Short Float1.84% Perf Quarter31.79%
Sales8.26B P/S8.71 EPS this Y198.90% Inst Trans20.61% Short Ratio2.12 Perf Half Y63.41%
Book/sh15.81 P/B13.31 EPS next Y35.49% ROA3.30% Target Price52.38 Perf Year56.54%
Cash/sh0.94 P/C223.19 EPS next 5Y22.80% ROE17.60% 52W Range106.00 - 211.57 Perf YTD47.03%
Dividend- P/FCF39.47 EPS past 5Y19.20% ROI8.40% 52W High-0.54% Beta0.91
Dividend %- Quick Ratio1.20 Sales past 5Y58.70% Gross Margin72.70% 52W Low98.51% ATR4.42
Employees16800 Current Ratio1.50 Sales Q/Q10.50% Oper. Margin34.80% RSI (14)59.61 Volatility2.24% 2.22%
OptionableYes Debt/Eq2.87 EPS Q/Q321.60% Profit Margin11.10% Rel Volume0.53 Prev Close209.39
ShortableYes LT Debt/Eq2.87 EarningsApr 29 BMO Payout0.00% Avg Volume2.88M Price210.42
Recom3.00 SMA203.20% SMA506.58% SMA20041.62% Volume1,515,396 Change0.49%
Feb-25-15Reiterated CRT Capital Buy $180 → $220
Feb-24-15Reiterated UBS Buy $165 → $222
Feb-24-15Reiterated Stifel Buy $175 → $230
Feb-12-15Reiterated RBC Capital Mkts Outperform $188 → $191
Feb-09-15Initiated Barclays Overweight $200
Jan-09-15Reiterated UBS Buy $155 → $165
Feb-28-14Reiterated UBS Buy $141 → $170
Feb-28-14Reiterated RBC Capital Mkts Outperform $151 → $158
Feb-27-14Reiterated Aegis Capital Buy $160 → $180
Jan-08-14Reiterated UBS Buy $125 → $141
Jan-08-14Reiterated Ladenburg Thalmann Buy $123 → $155
Jan-08-14Reiterated FBR Capital Outperform $130 → $153
Dec-03-13Reiterated UBS Buy $115 → $125
Nov-01-13Reiterated Ladenburg Thalmann Buy $127 → $123
Oct-30-13Initiated FBR Capital Outperform $130
Oct-07-13Reiterated CRT Capital Buy $110 → $130
Aug-08-13Reiterated UBS Buy $96 → $115
Aug-07-13Reiterated Aegis Capital Buy $135 → $140
Jul-02-13Reiterated RBC Capital Mkts Outperform $76 → $100
Jun-10-13Upgrade CRT Capital Hold → Buy $100
Apr-26-15 08:02AM  4 Top-Rated Drugmakers Reporting Earnings This Week at Investor's Business Daily
Apr-24-15 08:06PM  Endo International, a New Position for OZ Management
04:27PM  Will Ecolab's (ECL) Q1 Earnings Disappoint Estimates? - Analyst Blog
02:11PM  Valeant Pharmaceuticals Intl Inc (VRX), Apple Inc. (AAPL), McDonalds Corporation (MCD): A Look At Locust Woods Major First Quarter Moves at Insider Monkey
01:07PM  Teva, Mylan and Perrigo: Which Combination is Most Likely? at Barrons.com
09:45AM  RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain at noodls
09:30AM  RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain at noodls
09:14AM  RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain PR Newswire
09:14AM  RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain CNW Group
Apr-23-15 01:35PM  Will PMC-Sierra's (PMCS) Earnings Surprise this Season? - Analyst Blog
10:15AM  Will the Salix-Valeant story play out over and over again? at bizjournals.com
07:39AM  LLY CFO: Here's what's driving profits
12:36AM  Meet Pharmas Newest Movers and Shakers at The Wall Street Journal
Apr-22-15 09:22PM  Meet Pharma's Newest Movers and Shakers at The Wall Street Journal
07:06AM  Lone Pine Reduces Its Stake in Valeant Pharmaceuticals
06:14AM  Are M&A Replacing R&D In Pharma? at Forbes
Apr-21-15 08:14PM  Mylan plays monkey-in-the-middle of hostile takeover battles at Fortune
12:48PM  Ampio Plunges as STRIDE Study on Ampion Fails - Analyst Blog
10:19AM  Teva Pharmaceuticals Hopes $40 Billion Mylan Deal Will Fuel Stock Rebound at Forbes
Apr-20-15 03:15PM  Billionaire Andreas Halvorsens New Healthcare Pick at Insider Monkey
02:30PM  Will St. Jude Medical's (STJ) Earnings Miss the Mark in Q1? - Analyst Blog
Apr-18-15 11:00AM  Microsoft Corporation (MSFT), Valeant Pharmaceuticals Intl Inc (VRX): Partner Fund Managements Winning Bets in Healthcare and Tech at Insider Monkey
Apr-17-15 07:36PM  Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog
04:10PM  Pacira Down on Subpoena on Exparel Marketing Issues - Analyst Blog
10:25AM  Are Billions About to Be Made in Cosmetic Dermatology by 3 Companies? at 24/7 Wall St.
Apr-16-15 05:00PM  Pfizer's Ibrance Study Stopped Early on Favorable Data - Analyst Blog
04:30PM  Celsion Gains on Impressive Breast Cancer Study Data - Analyst Blog
11:41AM  Does Curtis Macnguyen really avoid hedge fund hotels? at MarketWatch
11:30AM  Amgen Gets FDA Nod for Chronic Heart Failure Drug Corlanor - Analyst Blog
11:20AM  Conatus Pharmaceuticals Inc (CNAT): Healthcor Takes Large Stake; See Conatus Needham Healthcare Conference Presentation Inside at Insider Monkey
09:32AM  Valeant Pharmaceuticals (VRX), CBS Corporation (CBS) and Sirius XM Holdings (SIRI) Pushed This Hedgie to 11.5% Q1 Returns at Insider Monkey
Apr-15-15 06:22PM  Roche Collaborates with Astellas Pharma for Tissue Diagnostics - Analyst Blog
06:06PM  Abbott Labs, Sekisui Medical to Offer Coagulation Tests - Analyst Blog
Apr-14-15 05:05PM  Life Time Fitness Deal: Material Adverse Change Explained, Part 2
05:05PM  Life Time Fitness Deal: Material Adverse Change Explained, Part 3
04:06PM  Magnetar Capital Lowers Its Stake in Shire
02:37PM  Roche Acquires CAPP Medical to Strengthen Cancer Diagnosis - Analyst Blog
11:06AM  Lone Pine Capital Sells Its Stake in Actavis
09:30AM  Valeant Pharma, Lindsay, Intel, Google and Microsoft highlighted as Zacks Bull and Bear of the Day - Press Releases
09:01AM  Bull of the Day: Valeant Pharma (VRX) - Bull of the Day
05:05AM  Lone Pine Adds New Stake in The Cooper Companies
Apr-13-15 05:17PM  Autohome, Other Foreign Stock Leaders Seen Posting Big Q1 at Investor's Business Daily
05:11PM  Pacira Announces Encouraging Data on Lead Drug Exparel - Analyst Blog
02:15PM  eBay Inc (EBAY), Yahoo! Inc. (YHOO), Valeant Pharmaceuticals (VRX): Ivory Capital Continues to Perform Well in Relative Anonymity at Insider Monkey
10:47AM  Why Mylan, Teva and Perrigo are This Year's Valeant, Allergan and Actavis at Barrons.com
Apr-12-15 11:10AM  Activist Jeffrey Ubbens Picks Blow Away S&P 500 Index in Q1 at Insider Monkey
Apr-11-15 11:51PM  The Top Guru-Held Canadian Stocks
Apr-10-15 05:26PM  Shire's SHP625 Fails in Phase II, FDA Accepts Lifitegrast NDA - Analyst Blog
12:17PM  Valeant VPs $50.6 Million Pay Second to Apple Among Non-CEOs at Bloomberg
10:18AM  Tiger Ratan Trumps Hedge Fund Industry in Q1; See How Nehal Chopras Stock Picks Performed at Insider Monkey
08:19AM  Analysts' Actions -- Cabela's, Weatherford, Whiting Petroleum and More
Apr-09-15 06:25PM  Specialty pharma; remember those two words: Cramer
04:55PM  Allergan drops lawsuit againt Valeant and Pershing Square at MarketWatch
02:40PM  Should Mylan Marry Perrigo Or Teva? Street Debates at Investor's Business Daily
01:00PM  Roche's Avastin's Label Expanded in EU for Cervical Cancer - Analyst Blog
12:51PM  Billionaire Paulson's Merger Hedge Fund Gains 10% in 2015
12:43PM  Valeant Pharmaceuticals Intl Inc (VRX), Ctrip.com International, Ltd. (ADR) (CTRP): Hound Partners Picks Absolutely Destroyed The Market in Q1 at Insider Monkey
11:51AM  Allergan, Valeant and Ackman End Legal Battle Over Failed Buyout at Bloomberg
11:37AM  Allergan, Valeant, Pershing Square Settle Lawsuits at The Wall Street Journal
10:50AM  Mylan Proposes to Acquire Perrigo, Sets Both Stocks Soaring - Analyst Blog
09:31AM  Billionaire Halvorsens Picks Dominated S&P 500 Index in Q1: Alibaba Group Holding Ltd (BABA), Valeant and More at Insider Monkey
08:20AM  Valeant Pharmaceuticals To Announce 2015 First Quarter Results On April 29, 2015 at noodls
08:00AM  Valeant Pharmaceuticals To Announce 2015 First Quarter Results On April 29, 2015 PR Newswire
08:00AM  Valeant Pharmaceuticals To Announce 2015 First Quarter Results On April 29, 2015 CNW Group
Apr-08-15 02:40PM  Shire Reaches Agreement with the FDA for ADHD Candidate - Analyst Blog
11:35AM  Billionaire Lee Ainslie Shows His Investing Acumen In Winners And Losers: Stock Picks Up 8.4% in Q1 at Insider Monkey
10:30AM  Bet on M&A Frenzy with These ETFs and Stocks - ETF News And Commentary
Apr-07-15 04:55PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, C
06:00AM  Valeant Clone Concordia Top Canada Stock as CEO Eyes Deal at Bloomberg
Apr-06-15 10:57AM  4Q14 Updates to Pershing Square Holdings
Apr-02-15 04:50PM  Valeant to lay off 258 Salix workers in North Carolina at bizjournals.com
02:31PM  Actavis plc (ACT), Valeant Pharmaceuticals Intl Inc (VRX) & More: Top Healthcare Picks Among Hedge Funds Crushed Mr. Market at Insider Monkey
02:25PM  3 JPMorgan Bull Calls Hitting The Market
08:45AM  Morning Movers: CarMax Gains on Earnings; Lumber Liquidators Rises at Barrons.com
Apr-01-15 05:50PM  CNO Financial Group Set to Join the S&P MidCap 400 PR Newswire
05:21PM  Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Salix Pharmaceuticals at noodls
05:21PM  Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 at noodls
05:21PM  Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 at noodls
05:00PM  Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 PR Newswire
05:00PM  Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 CNW Group
05:00PM  Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 PR Newswire
05:00PM  Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 CNW Group
03:06PM  Life Time Fitness Deal: Material Adverse Change Explained, Part 1
03:05PM  Rationale for the Life Time Fitness Merger
03:02PM  Twitter Inc (TWTR), Kraft Foods Group Inc (KRFT), Valeant Pharmaceuticals Intl Inc (VRX): The 3 Biggest Large Cap Gainers of the First Quarter at Insider Monkey
02:52PM  Drugmaker Valeant completes $11 billion purchase of Salix
02:05PM  The Risk-to-Reward Ratio of the Life Time Fitness Merger
01:07PM  Is the Life Time Fitness Deal a Setup?
12:35PM  Valeant closes $11B deal for Raleigh's Salix Pharmaceuticals at bizjournals.com
09:19AM  Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 at noodls
09:05AM  Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 PR Newswire
09:05AM  Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 CNW Group
09:00AM  Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Salix Pharmaceuticals PR Newswire
09:00AM  Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Salix Pharmaceuticals CNW Group
07:00AM  Health Care: 3 Picks in a More Expensive Sector at Morningstar
06:13AM  Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. at noodls
06:00AM  Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. PR Newswire
06:00AM  Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. CNW Group
01:00AM  Pharma's Comeback Deals Keep Drug M&A on Track to Reach Records
Mar-31-15 03:16PM  Charter Communications, Inc. (CHTR): Ratan Capital Group Stays Hot As Stock Soars on Bright House Purchase at Insider Monkey
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer. It also provides Zovirax, an antiviral for recurrent herpes labialis and initial genital herpes; Syprine to treat patients with Wilson's disease; Elidel to treat atopic dermatitis; Prolensa for inflammation and pain following cataract surgery; Duromine, a weight loss drug; and Lotemax gel for post-operative inflammation and pain. In addition, the company offers PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; ReNu Multiplus to lubricate and rewet soft contact lenses; Biotrue for healthy contact lens wear; Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; AntiGrippin for acute respiratory and respiratory viral diseases, and influenza; and Bedoyecta, a vitamin B complex product. Further, it provides SofLens daily disposable contact lenses; PureVision, a contact lens; various ophthalmic surgical products; Biotrue ONEday lens; medical device systems for aesthetic applications; and Bausch + Lomb Ultra, a contact lens. Additionally, the company offers Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Cardizem CD to treat hypertension and angina; and Latanoprost for the treatment of glaucoma. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kornwasser LaizerEVP, Company Group ChairmanApr 17Option Exercise0.0045,0000123,377Apr 21 05:46 PM
Mirovsky PavelPresident, EMENAApr 15Option Exercise0.0024,175034,175Apr 17 05:28 PM
Chai-Onn Robert RoswellEVP, CLO, General CounselMar 03Option Exercise6.1021,808133,02943,187Mar 04 05:24 PM
Chai-Onn Robert RoswellEVP, CLO, General CounselMar 02Option Exercise25.4290,9392,311,669112,296Mar 04 05:24 PM
Chai-Onn Robert RoswellEVP, CLO, General CounselMar 02Sale200.0190,93918,189,09121,379Mar 04 05:24 PM
Mirovsky PavelEVP, Pres. & GM Valeant EMEAFeb 27Option Exercise0.0010,000010,000Mar 02 05:16 PM
Stolz Brian M.EVP, Administration and CHCOJan 22Option Exercise0.007,350095,934Jan 26 05:22 PM
Schiller Howard BradleyEVP, Chief Financial OfficerJan 05Option Exercise0.0045,0000318,714Jan 07 05:38 PM
Stolz Brian M.EVP, CHCO and AdministrationDec 23Option Exercise0.0015,426096,618Dec 24 10:31 AM
Farmer Ronald HaroldDirectorDec 12Buy160.4850080,24033,004Dec 16 02:59 PM
UBBEN JEFFREY WDirectorDec 10Buy139.2950,0006,964,50018,030,936Dec 11 06:59 PM
UBBEN JEFFREY WDirectorDec 09Buy140.25200,00028,050,00017,980,936Dec 11 06:59 PM
STEVENSON KATHARINE BERGHUISDirectorDec 03Buy145.731,500218,59523,098Dec 03 04:48 PM
Farmer Ronald HaroldDirectorNov 24Buy163.951,000163,95032,504Dec 01 05:25 PM
UBBEN JEFFREY WDirectorNov 24Buy142.25210,00029,872,50017,780,936Nov 26 04:11 PM
Stolz Brian M.EVP, Administration and CHCOOct 10Option Exercise0.003,675084,791Oct 14 02:51 PM
Schiller Howard BradleyEVP and CFOOct 03Option Exercise0.0022,5000285,500Oct 07 04:19 PM
Stolz Brian M.EVP, Administration and CHCOSep 30Option Exercise0.0023,030093,064Oct 02 03:52 PM
Stolz Brian M.EVP, CHCO and AdministrationAug 06Option Exercise0.0018,111079,431Aug 07 03:53 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Jun 23Option Exercise6.4510,20365,80934,202Jun 24 04:37 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Jun 23Sale121.7010,2031,241,67623,999Jun 24 04:37 PM
Mirovsky PavelPresident of Valeant EuropeJun 02Sale131.2510,0001,312,4860Jun 04 03:19 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.May 13Option Exercise6.4510,00064,50033,999May 14 04:29 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.May 13Sale130.0810,0001,300,83623,999May 14 04:29 PM